15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 7 firms covering Immunocore Holdings Ltd, 4 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $33.00 to $100.00 (about 3.0x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $59.83 sits 79% above the current $33.47. The rating mix has stayed broadly stable, with Buy-side ratings easing from 5 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.00 next quarter toward $-0.52 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS7 ratings
Moderate Buy
Strong Buy00%
Buy457%
Hold343%
Sell00%
Strong Sell00%
Based on 7 analysts giving stock ratings to Immunocore Holdings Ltd.
As of Jul, 4 of 7 firms rate IMCR a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
IMCR EPS & revenue forecast
EPS · NEXT QUARTER
$0.00
Range $-0.19 – $0.31 · 10 analysts
Next period, 10 analysts expect Immunocore Holdings Ltd to earn $0.00 a share (range $-0.19 – $0.31), versus $0.00 a year earlier. Full-year consensus is $0.16, growing to $-0.52 the year after.
REVENUE · NEXT QUARTER
$113.5M
Range $109.6M – $119.0M · 10 analysts · +9% YoY
Revenue is expected to reach $113.5M (range $109.6M – $119.0M), +9.4% year-over-year. Full-year consensus is $446.4M, rising to $487.4M next year.
Top analysts covering Immunocore Holdings Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on IMCR.
#1
Michael Schmidt
Guggenheim · Rank #1
Hold
No targeton IMCR
Overall win rate
55%
+ Follow
#2
Jessica Fye
JP Morgan · Rank #64
Buy
$50.00+49.4% to target
Overall win rate
52%
+ Follow
#3
Jeff Jones
Oppenheimer · Rank #197
Buy
$86.00+156.9% to target
Overall win rate
34%
+ Follow
#4
Patrick R. Trucchio
HC Wainwright & Co. · Rank #203
Buy
$100.00+198.8% to target
Overall win rate
35%
+ Follow
#5
Gil Blum
Needham · Rank #298
Buy
$75.00+124.1% to target
Overall win rate
24%
+ Follow
IMCR stock forecast FAQ
What is IMCR's average 12-month price target?+
The 6 analysts with a live target average $59.83 for Immunocore Holdings Ltd over the next 12 months, ranging from a $100.00 high to a $33.00 low.
Is IMCR stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 7 analyst ratings, 4 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for IMCR?+
The Street-high target is $100.00 (HC Wainwright & Co.), and the Street-low is $33.00 (Jefferies). The average of all 6 active targets is $59.83.
How many Wall Street analysts cover IMCR?+
7 analysts have an active rating on Immunocore Holdings Ltd, and 6 firms carry a live 12-month price target.
Who is the most accurate analyst covering IMCR?+
Among analysts who currently cover IMCR, Michael Schmidt of Guggenheim has the strongest overall Quantellect track record (Rank #1). Their current call is Hold.
What is Immunocore Holdings Ltd's projected EPS for next quarter?+
The consensus estimate is $0.00 per share (range $-0.19 – $0.31) across 10 analysts. Full-year EPS is projected at $0.16, rising to $-0.52 the following year.
How much revenue is Immunocore Holdings Ltd expected to report next quarter?+
Consensus revenue is $113.5M (range $109.6M – $119.0M). Full-year revenue is projected at $446.4M, growing to $487.4M next year.
Have analysts been upgrading or downgrading IMCR lately?+
As of Jul, 4 of 7 firms rate IMCR a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their IMCR calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
